NCT03451396View on ClinicalTrials.gov

Effect of Lifitegrast on Dry Eye Disease Signs and Symptoms

PHASE4CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

December 12, 2016

Primary Completion Date

February 1, 2018

Study Completion Date

March 15, 2018

Conditions
Dry Eye
Interventions
DRUG

Lifitegrast

All subjects meet dry eye inclusion and will be treated with Lifitegrast gtts BID

Trial Locations (1)

63017

Lifelong Vision Foundation, Chesterfield

All Listed Sponsors
lead

Lifelong Vision Foundation

OTHER

NCT03451396 - Effect of Lifitegrast on Dry Eye Disease Signs and Symptoms | Biotech Hunter | Biotech Hunter